From Seekingalpha · Julia Ostian · · 50s
Northrop Grumman Q3 Preview: Bad News Priced In
Northrop Grumman stock near 52-week lows despite strong Q2 results and record backlog.
In brief
Northrop Grumman stock near 52-week lows despite strong Q2 results and record backlog. Northrop Grumman's Q3 results expected to show margin pressures but valuation at 16.8x 2026 EPS guidance makes it a defensive buy. Originally reported by Seekingalpha.
Northrop Grumman Q3 Preview
Northrop Grumman trades near 52-week lows despite record backlog, raised guidance, and accelerating key programs like B-21 and Sentinel.
Q2 Results Show Strength
NOC's Q2 results showed strong sales and backlog growth, but margin pressures from program charges and timing risks around government funding persist.
Attractive Entry Point
Valuation at 16.8x 2026 EPS guidance presents an attractive entry, with a 2% dividend yield and low expectations ahead of Q3 earnings.
Investment Strategy
I favor starting a position before results, keeping dry powder for post-earnings volatility if margin or cash flow disappointments drive further downside.
The main idea
Northrop Grumman's Q3 results expected to show margin pressures but valuation at 16.8x 2026 EPS guidance makes it a defensive buy.
